Company Overview
Generating analyst summary…
Log in to access full profile ›Company Intelligence Q&A
- What is S.T. Stent's core product?
- S.T. Stent develops a composite, removable sinus stent designed to keep the ethmoid sinus cavity open for up to 28 days after functional endoscopic sinus surgery, aiming to improve patient outcomes and reduce revision surgeries.
- When did S.T. Stent receive FDA clearance for its sinus stent?
- S.T. Stent was awarded FDA clearance for its sinus stent in January 2018, as reported by multiple sources including Medgadget and PR Newswire.
- Which investors participated in S.T. Stent's November 2022 funding round?
- In November 2022, S.T. Stent received funding from ExitValley and The Trendlines Group.
- When did S.T. Stent complete a $450k raise?
- S.T. Stent completed a $450k raise in April 2015, with participation from The Trendlines Group.